Article
Characterization of novel CD19-specific VHHs isolated from a camelid immune library by phage display
8 Dec 2023
Abstract excerpt
Abstract Background Monoclonal antibody (mAb)-based immunotherapies have achieved promising outcomes in the treatment of immunological and oncological indications. CD19 is considered one of the most qualified antigens in the treatment of B-cell neoplasms. VHHs (nanobodies) are known for their physicochemical advantages over conventional mAbs rendering them suitable therapeutics and diagnostic tools. Herein, we...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
